Data as of Dec 11
| -0.47 / -0.60%|
The 24 analysts offering 12-month price forecasts for Novartis AG have a median target of 83.94, with a high estimate of 95.67 and a low estimate of 67.79. The median estimate represents a +8.25% increase from the last price of 77.54.
The current consensus among 30 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.